The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124532142 12453214 2 F 20160427 20160908 20160609 20160915 EXP US-MYLANLABS-2016M1023128 MYLAN 0.00 Y 0.00000 20160915 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124532142 12453214 1 PS PROPAFENONE. PROPAFENONE 1 Oral 75 MG, TID U U 203803 75 MG TID
124532142 12453214 2 SS DIGOXIN MYLAN DIGOXIN 1 Oral 250 MG, QD U U 0 250 MG QD
124532142 12453214 3 SS CAPECITABINE. CAPECITABINE 1 Oral 2000 MG, BID 780000 MG Y 0 2000 MG BID
124532142 12453214 4 SS PLACEBO UNSPECIFIED INGREDIENT 1 Oral 20 MG, BID 7800 MG Y U 0 20 MG BID
124532142 12453214 5 SS PREGABALIN. PREGABALIN 1 Oral 150 MG, BID 3900 MG Y U UNK 0 150 MG BID
124532142 12453214 6 SS PREGABALIN. PREGABALIN 1 Oral 175 MG, BID U U 0 175 MG BID
124532142 12453214 7 C DOCUSATE SODIUM. DOCUSATE SODIUM 1 UNK U UNK 0
124532142 12453214 8 C SENNA /00142201/ SENNA LEAF 1 UNK UNK 0
124532142 12453214 9 C OMEPRAZOLE. OMEPRAZOLE 1 UNK UNK 0
124532142 12453214 10 C CREON PANCRELIPASE AMYLASEPANCRELIPASE LIPASEPANCRELIPASE PROTEASE 1 UNK 0
124532142 12453214 11 C PHENOXYMETHYLPENICILLIN PENICILLIN V 1 UNK 0
124532142 12453214 12 C APIXABAN APIXABAN 1 UNK UNK 0
124532142 12453214 13 C ALFUZOSIN ALFUZOSIN 1 UNK UNK 0
124532142 12453214 14 C CARBIMAZOLE CARBIMAZOLE 1 UNK UNK 0
124532142 12453214 15 C ATENOLOL. ATENOLOL 1 UNK UNK 0
124532142 12453214 16 C OXYCODONE OXYCODONE 1 UNK U UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124532142 12453214 1 Atrial fibrillation
124532142 12453214 2 Atrial fibrillation
124532142 12453214 3 Pancreatic carcinoma
124532142 12453214 4 Pancreatic carcinoma
124532142 12453214 5 Abdominal pain
124532142 12453214 6 Abdominal pain

Outcome of event

Event ID CASEID OUTC COD
124532142 12453214 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
124532142 12453214 Confusional state
124532142 12453214 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124532142 12453214 1 2012 0
124532142 12453214 2 201507 0
124532142 12453214 3 20151001 20160412 0
124532142 12453214 4 20151001 20160412 0
124532142 12453214 5 20160415 20160427 0
124532142 12453214 6 20160427 0
124532142 12453214 7 20160416 0
124532142 12453214 8 201507 0
124532142 12453214 9 2014 0
124532142 12453214 11 20141119 0
124532142 12453214 12 20160229 0
124532142 12453214 13 2011 0
124532142 12453214 14 2009 0
124532142 12453214 15 2007 0
124532142 12453214 16 20160416 0